Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT06828861
PHASE3

ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial

Sponsor: Aardvark Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if ARD-101 works to treat hyperphagia-related behavior in patients with Prader-Willi syndrome (PWS). It will also teach us about the safety of ARD-101. The main questions it aims to answer are: * Does ARD-101 improve the total score of the HQCT-9 (hyperphagia questionnaire for clinical trials, 9 questions)? * What medical problems do participants have when taking ARD-101? Researchers will compare ARD-101 to a placebo (a look-alike substance that contains no drug) to see if ARD-101 works to treat hyperphagia in PWS subjects. Eligible participants will: * Take ARD-101 or a placebo every day for 12 weeks. * Visit the clinic or have a tele-visit once every 2 to 4 weeks during dosing and then have a tele-visit 4 weeks after stopping the ARD-101 or placebo. * Patients/Caregivers will keep a daily diary. Participants who complete the study may be eligible to enter an open-label extension study where everyone will receive ARD-101.

Official title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ARD-101 for the Treatment of Hyperphagia in Patients With Prader-Willi Syndrome

Key Details

Gender

All

Age Range

7 Years - Any

Study Type

INTERVENTIONAL

Enrollment

68

Start Date

2024-12-20

Completion Date

2026-05-07

Last Updated

2026-06-30

Healthy Volunteers

No

Interventions

DRUG

Placebo

200 mg BID (twice per day) for 1 week, 400 mg BID for 1 week, 800 mg BID for 10 weeks

DRUG

ARD-101

200 mg BID (twice per day) for 1 week, 400 mg BID for 1 week, 800 mg BID for 10 weeks

Locations (31)

Children's of Alabama

Birmingham, Alabama, United States

Rady Children's Hospital

Encinitas, California, United States

Children's Hospital of Orange Country

Orange, California, United States

Stanford Children's Health Specialty Services

Palo Alto, California, United States

Children's Hospital Colorado

Denver, Colorado, United States

Nemours Children Clinic Wilmington

Wilmington, Delaware, United States

UF Shands Children's Hospital

Gainesville, Florida, United States

Emory University School of Medicine

Atlanta, Georgia, United States

Ann and Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

The Johns Hopkins Hospital

Baltimore, Maryland, United States

University of Minnesota Masonic Children's Hospital

Minneapolis, Minnesota, United States

Maimonides Medical Center

Brooklyn, New York, United States

NYU Langone Children's Ambulatory Care Center

Mineola, New York, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Cook Children's Medical Center

Fort Worth, Texas, United States

Texas Valley Clinical Research, LLC

Weslaco, Texas, United States

Seattle Children's Hospital

Seattle, Washington, United States

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

The Children's Hospital at Westmead

Westmead, New South Wales, Australia

Queensland Children's Hospital

South Brisbane, Queensland, Australia

Alberta Children's Hospital Research Institute

Calgary, Alberta, Canada

Stollery Children's Hospital

Edmonton, Alberta, Canada

Children's Hospital at London Health Sciences Centre

London, Ontario, Canada

Centre Hospitalier Universitaire Sainte-Justine

Montreal, Quebec, Canada

Inha University Hospital

Incheon, South Korea

Samsung Medical Center

Seoul, South Korea

Ajou University Hospital

Suwon, South Korea

Leicester Royal Infirmary

Leicester, Leicestershire, United Kingdom

Fulborn Hospital

Cambridge, United Kingdom

Royal Hospital for Children (Glasgow) - PPDS - PIN

Glasgow, United Kingdom

The Royal London Hospital

London, United Kingdom